NCT05378282View on ClinicalTrials.gov

Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Type 2 DiabetesType 2 Diabetes With Renal Manifestations
Trial Locations (1)

07760

Hospital Juárez de México, Mexico City

All Listed Sponsors
lead

Hospital Juarez de Mexico

OTHER_GOV

NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics | Biotech Hunter | Biotech Hunter